Company China National Accord Medicines Corporation Ltd.
Equities
000028
CNE0000009N6
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.21 CNY | +0.94% | -0.82% | +4.21% |
Oct. 26 | China National Accord Medicines' Profit Slides 4% in Q3 | MT |
Oct. 26 | China National Accord Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Business Summary
Number of employees: 39,296
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Distribution
67.2
%
| 45,877 | 67.1 % | 49,336 | 67.2 % | +7.54% |
Pharmaceutical Retail
32.8
%
| 22,475 | 32.9 % | 24,104 | 32.8 % | +7.25% |
Head Office
0.0
%
| 6 | 0.0 % | 3 | 0.0 % | -43.30% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 68,358 | 100.0 % | 73,443 | 100.0 % | +7.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhao Xiong Lin
CEO | Chief Executive Officer | 57 | 08-11-30 |
Guo Lin Gu
DFI | Director of Finance/CFO | 49 | 20-05-27 |
Min Lin
CHM | Chairman | 59 | 08-11-30 |
Zhao Yu Wang
IRC | Investor Relations Contact | - | - |
Chang Bing Chen
SEC | Corporate Secretary | 57 | 00-11-30 |
Xin Yang Lin
PRN | Corporate Officer/Principal | 60 | 04-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Zhao Xiong Lin
CEO | Chief Executive Officer | 57 | 08-11-30 |
Min Lin
CHM | Chairman | 59 | 08-11-30 |
Yi Jian Wu
BRD | Director/Board Member | 54 | 20-11-12 |
Yong Liu
BRD | Director/Board Member | 55 | 16-12-31 |
Hong Hui Chen
BRD | Director/Board Member | 53 | 17-03-13 |
Xiao Juan Li
BRD | Director/Board Member | 48 | 21-05-31 |
De Yong Wen
CHM | Chairman | 52 | 19-07-09 |
Wei Wei Su
BRD | Director/Board Member | 65 | 19-01-23 |
Xin Yi
BRD | Director/Board Member | 49 | 22-07-17 |
Guo Jing Chen
BRD | Director/Board Member | 54 | 18-08-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 71,349,817 | 70,636,319 ( 99.00 %) | 0 | 42.57 % |
Stock B | 1 | 485,215,260 | 166,288,457 ( 34.27 %) | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
167,142,202 | 12.46% | 211,912,912 $ |
Company contact information
China National Accord Medicines Corp. Ltd.
Accord Pharmaceutical Building 15, Bagua 4th Road
518029, Shenzhen
+86 755 2587 5140
http://www.szaccord.com.cnSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.24% | 2.14B | |
+16.48% | 70.86B | |
+11.65% | 27.37B | |
-1.96% | 8.14B | |
+1.91% | 7.92B | |
-25.23% | 7.51B | |
+1.40% | 4.65B | |
+10.56% | 4.08B | |
+2.96% | 4.12B | |
-4.65% | 3.92B |
- Stock
- Equities
- Stock China National Accord Medicines Corporation Ltd. - Shenzhen S.E.
- Company China National Accord Medicines Corporation Ltd.